Company Search:
Advanced Search
Sponsored Links
Hainan Shuangcheng Pharmaceuticals Co Ltd Company Snapshot
Hainan Shuangcheng Pharmaceuticals Co Ltd operates within the Pharmaceutical preparations sector. In addition to historical fundamental analyses, the complete report available to purchase compares Hainan Shuangcheng Pharmaceuticals Co Ltd with three other companies in this sector in China: Hangzhou Tianmuhan Pharmaceutical Enterprise Co., Ltd. (2016 sales of 123.62 million Chinese Renmimbi [US$19.35 million] of which 78% was Medicine), China Health Industries Holdings Incorporation (50.42 million Chinese Renmimbi [US$7.89 million] ), and Zhejiang Ausun Pharmaceutical Co Ltd (198.84 million Chinese Renmimbi [US$31.12 million] ).

Sales Analysis. During the year ended December of 2016, sales at Hainan Shuangcheng Pharmaceuticals Co Ltd were 145.12 million Chinese Renmimbi (US$22.71 million). This is a sharp decrease of 37.2% versus 2015, when the company's sales were 230.93 million Chinese Renmimbi. The sales level in 2016 was fairly close to the level five years ago: in 2011, Hainan Shuangcheng Pharmaceuticals Co Ltd had sales of 133.50 million Chinese Renmimbi. Contributing to the drop in overall sales was the 46.2% decline in Agent Medicines Business, from 33.99 million Chinese Renmimbi to 18.28 million Chinese Renmimbi. There were also decreases in sales in Self-Made Medicine Business (down 35.9% to 125.80 million Chinese Renmimbi) . However, these declines were partially offset by the increase in sales of Other Business (up 34.4% to 1.10 million Chinese Renmimbi) .
Company ReportsSubscriptions
Looking For More?
Purchace an In-Depth Report
Hainan Shuangcheng Pharmaceuticals Co Ltd
  Stock Performance Chart for Hainan Shuangcheng Pharmaceuticals Co Ltd
  Stock Data: Recent Stock Performance:
  Current Price (5/25/2018): 7.67
(Figures in Chinese Renmimbi)
1 Week 1.6%   13 Weeks 19.7%  
4 Weeks 54.9%   52 Weeks 15.0%  
Hainan Shuangcheng Pharmaceuticals Co Ltd Key Data:
  Ticker: 002693 Country: China
  Exchanges: SZN Major Industry: Pharmaceuticals & Biotechnology
    Sub Industry: Pharmaceutical Preparations
  2016 Sales 145,122,308
(Year Ending Jan 2017).
Employees: 543
  Currency: Chinese Renmimbi Market Cap: 3,106,350,000
  Fiscal Yr Ends: December Shares Outstanding: 405,000,000
  Share Type: A Gu Closely Held Shares: 239,154,349
Sponsored Links
Feedback | Terms and Conditions | Privacy Policy | Site Index
CorporateInformation® website and selected data Copyright © 2000 - by The Winthrop Corporation. All Rights Reserved. Except for quotations by established news media, no pages on this site may be reproduced, stored in a retrieval system, or transmitted for commercial purposes, in any form or by any means, electronic, mechanical, photocopying, recording, or otherwise without prior written permission. Information is believed reliable, but accuracy, completeness and opinions are not guaranteed.